Navigation Links
Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing

Japanese Pharmaceutical Company and Chinese Biotech Company join hands to form a new venture for production of drugs and clinical trials.

The Japanese company GNI merged with Chinese company Shanghai Genomics. // The wet lab facilities and validation would be done by Shanghai Genomics. China will be testing new lead compounds produced by GNI, such as new compounds for lung fibrosis and lung injury, such as damage from cancer radiotherapy, will be tested by china. China has about 300 million smokers and air pollution is high causing damaged lungs, which offers good atmosphere for testing of this new compound.

Ames Gross, President Pacific Bridge Medical is not happy with the mergers and is very much afraid of the potential problems such as copycats and piracy of the drugs. “Small companies that lack the resource to protect their IP in court need to be especially careful when thinking about sharing their inventions. Regulations and enforcement in places like China and India is improving, but it’s still possible to get burned.”

The merger would help intensify research in china in the field of medicine and drug discovery. This offer opens a new gate way of out-sourcing in the field of molecular biology, medicinal chemistry and pre-clinical testing to china. China offers low costs, access to large patients for clinical trials and rapidly growing market. “In the near future, Japan and China will be the world’s second and fifth largest pharmaceutical markets,” says Christopher Savoie, GNI’s chief executive.

(Source: Nature Biotechnoogy)
'"/>




Page: 1

Related medicine news :

1. 45 People die in West Bengal due to Dengue and suspected Japanese Encephalitis
2. Woman Tests Negative For Japanese Encephalitis: Health Minister
3. Japanese-Indonesian Joint Venture To Produce Bird Flu Vaccine For Farm Animals
4. Schools set to offer Japanese language course
5. Girlie Needle And Thread help Japanese Men to De-Stress
6. Japanese Encephalitis Immunization Programme in India
7. Leprosy Cured People In India To Be Trained By Japanese Trust
8. Uttar Pradesh To Prepone The Japanese Encephalitis Immunisation Drive
9. Japanese Face High Risk Of Heart Attack And Stroke, Metabolic Syndrome to Blame
10. Japanese Scientists Develop Thought-Controlled Robotic Hands
11. Japanese Court Rules In Patients Favour Over Hepatitis C Scandal
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with ... Latin America . ... ... ... ...
Breaking Medicine Technology: